DMAC
Price
$6.62
Change
-$0.06 (-0.90%)
Updated
Aug 17 closing price
Capitalization
356.99M
92 days until earnings call
Intraday BUY SELL Signals
RAPP
Price
$48.42
Change
+$1.00 (+2.11%)
Updated
Aug 17 closing price
Capitalization
2.32B
79 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DMAC vs RAPP

DMAC vs RAPP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
DMAC vs. RAPP commentary
Aug 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DMAC is a Buy and RAPP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2026
Stock price -- (DMAC: $6.62 vs. RAPP: $48.42)
Brand notoriety: DMAC and RAPP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DMAC: 51% vs. RAPP: 39%
Market capitalization -- DMAC: $356.99M vs. RAPP: $2.32B
DMAC [@Biotechnology] is valued at $356.99M. RAPP’s [@Biotechnology] market capitalization is $2.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $130.67B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DMAC’s FA Score shows that 0 FA rating(s) are green whileRAPP’s FA Score has 1 green FA rating(s).

  • DMAC’s FA Score: 0 green, 5 red.
  • RAPP’s FA Score: 1 green, 4 red.
According to our system of comparison, RAPP is a better buy in the long-term than DMAC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DMAC’s TA Score shows that 6 TA indicator(s) are bullish while RAPP’s TA Score has 4 bullish TA indicator(s).

  • DMAC’s TA Score: 6 bullish, 2 bearish.
  • RAPP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, DMAC is a better buy in the short-term than RAPP.

Price Growth

DMAC (@Biotechnology) experienced а -0.45% price change this week, while RAPP (@Biotechnology) price change was +3.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.12%. For the same industry, the average monthly price growth was +0.13%, and the average quarterly price growth was +2708.80%.

Reported Earning Dates

DMAC is expected to report earnings on Nov 18, 2026.

RAPP is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (+0.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RAPP($2.32B) has a higher market cap than DMAC($357M). RAPP YTD gains are higher at: 59.591 vs. DMAC (-16.834). DMAC has higher annual earnings (EBITDA): -36.69M vs. RAPP (-121.21M). RAPP has more cash in the bank: 477M vs. DMAC (51.3M). DMAC has less debt than RAPP: DMAC (212K) vs RAPP (10.8M). RAPP has higher revenues than DMAC: RAPP (20M) vs DMAC (0).
DMACRAPPDMAC / RAPP
Capitalization357M2.32B15%
EBITDA-36.69M-121.21M30%
Gain YTD-16.83459.591-28%
P/E RatioN/A21.81-
Revenue020M-
Total Cash51.3M477M11%
Total Debt212K10.8M2%
FUNDAMENTALS RATINGS
DMAC: Fundamental Ratings
DMAC
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DMACRAPP
RSI
ODDS (%)
N/A
Bearish Trend 5 days ago
80%
Stochastic
ODDS (%)
Bullish Trend 5 days ago
82%
Bearish Trend 5 days ago
90%
Momentum
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 5 days ago
84%
MACD
ODDS (%)
Bullish Trend 5 days ago
88%
Bullish Trend 5 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 5 days ago
82%
Bullish Trend 5 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 5 days ago
80%
Bullish Trend 5 days ago
90%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 8 days ago
90%
Declines
ODDS (%)
Bearish Trend 5 days ago
80%
Bearish Trend 6 days ago
77%
BollingerBands
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
Aroon
ODDS (%)
Bearish Trend 5 days ago
74%
Bullish Trend 5 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
DMAC
Daily Signal:
Gain/Loss:
RAPP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
COPZ17.060.69
+4.19%
Defiance Daily Target 2X Long Copper ETF
ARKQ130.470.08
+0.06%
ARK Autonomous Technology&Robotics ETF
IMAR31.33-0.03
-0.08%
Innovator Intl Dev Pwr Bffr ETF - Mar
JMSI49.48-0.12
-0.25%
JPMorgan Sustainable Municipal Inc ETF
MMMA25.07-0.08
-0.30%
NYLI MacKay Muni Allocation ETF

DMAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMAC has been loosely correlated with EDIT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if DMAC jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMAC
1D Price
Change %
DMAC100%
-0.90%
EDIT - DMAC
45%
Loosely correlated
+0.71%
ANNX - DMAC
39%
Loosely correlated
-3.02%
PRME - DMAC
38%
Loosely correlated
+2.59%
KRRO - DMAC
38%
Loosely correlated
-1.05%
FDMT - DMAC
37%
Loosely correlated
+19.32%
More

RAPP and

Correlation & Price change

A.I.dvisor indicates that over the last year, RAPP has been loosely correlated with ACRV. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if RAPP jumps, then ACRV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RAPP
1D Price
Change %
RAPP100%
+2.11%
ACRV - RAPP
37%
Loosely correlated
+5.13%
DMAC - RAPP
36%
Loosely correlated
-0.90%
PRAX - RAPP
35%
Loosely correlated
+2.61%
FTRE - RAPP
35%
Loosely correlated
+3.96%
DNTH - RAPP
34%
Loosely correlated
-0.95%
More